Day: June 6, 2026

Neuroplastic Horizons: AI-Driven Biomarker Tracking in Ketamine Protocols

Introduction: The Convergence of Psychiatry and Precision Technology The landscape of mental health treatment is undergoing a fundamental shift as the administration of ketamine for treatment-resistant depression moves from clinical trial settings to mainstream psychiatric practice. Says Dr. Austin Harris, this transition requires a move away from purely subjective patient reporting toward objective, data-driven assessments […]